Go Pro

Xylem Inc. $XYL Shares Sold by Handelsbanken Fonder AB

Xylem logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Handelsbanken Fonder AB reduced its Xylem stake by 37.4% in the second quarter, selling 210,581 shares and retaining 352,869 shares valued at approximately $41.7 million. Institutional investors and hedge funds collectively own 87.96% of the company.
  • Xylem reported quarterly EPS of $1.46, beating the $1.34 analyst consensus, while revenue reached $2.34 billion and rose 1.5% year over year. The company issued fiscal 2026 EPS guidance of $5.55–$5.70.
  • The company declared a quarterly dividend of $0.43, equal to an annualized $1.72 and a 1.4% yield. Analysts give Xylem a consensus “Moderate Buy” rating with an average price target of $154, compared with shares opening at $123.10.
  • MarketBeat previews the top five stocks to own by September 1st.

Handelsbanken Fonder AB trimmed its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 37.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 352,869 shares of the industrial products company's stock after selling 210,581 shares during the quarter. Handelsbanken Fonder AB owned about 0.15% of Xylem worth $41,713,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. J. Stern & Co. LLP increased its stake in shares of Xylem by 12,326.6% during the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company's stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares during the period. Norges Bank acquired a new stake in Xylem in the fourth quarter worth approximately $361,012,000. SEB Asset Management AB bought a new position in Xylem during the 1st quarter valued at $66,700,000. Balyasny Asset Management L.P. increased its position in shares of Xylem by 346.2% during the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company's stock valued at $105,160,000 after purchasing an additional 553,152 shares during the period. Finally, Adage Capital Partners GP L.L.C. acquired a new position in shares of Xylem during the 2nd quarter valued at $64,407,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Price Performance

Shares of NYSE:XYL opened at $123.10 on Wednesday. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The stock has a fifty day moving average of $116.83 and a 200-day moving average of $120.95. The company has a market capitalization of $28.74 billion, a PE ratio of 29.31, a price-to-earnings-growth ratio of 1.68 and a beta of 1.02. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to analysts' expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The company's quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, equities analysts anticipate that Xylem Inc. will post 5.67 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. Xylem's dividend payout ratio (DPR) is currently 40.95%.

Analyst Ratings Changes

XYL has been the subject of several research analyst reports. UBS Group upped their price objective on Xylem from $129.00 to $135.00 and gave the company a "neutral" rating in a report on Thursday, July 30th. Robert W. Baird lifted their target price on Xylem from $163.00 to $165.00 and gave the stock an "outperform" rating in a report on Wednesday, July 29th. CLSA upgraded shares of Xylem to a "hold" rating in a research report on Thursday, June 25th. Weiss Ratings reissued a "hold (c)" rating on shares of Xylem in a report on Wednesday, August 5th. Finally, Jefferies Financial Group upgraded shares of Xylem from a "hold" rating to a "buy" rating and raised their price objective for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. Nine analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $154.00.

View Our Latest Report on XYL

Xylem Company Profile

(Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Read More

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines